Новые подходы к диагностическому алгоритму отечно-инфильтративной формы рака молочной железы (обзор литературы)
Аннотация
Ключевые слова
Об авторах
Антонина Юрьевна КолесникРоссия
Мария Андреевна Шершнева
Россия
Елена Валерьевна Меских
Россия
Владимир Давыдович Чхиквадзе
Россия
Николай Васильевич Нуднов
Россия
Список литературы
1. Robertson F.M., Bondy М., Yang W. et al. Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J. Clin. 2010; 60 (6): 351-375.
2. Dawood S., Merajver S.D., Viens P. et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann. Oncol. 2011; 22 (3): 515-523.
3. Sunil R. Lakhani, Ian O. Ellis, Stuart J. Schnittet et al. WHO Classification of Tumors of the Breast 4th Edition. Geneva: World Health Organization, 2012. 67-68.
4. Schairer C., Soliman A.S., Omar S. Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. Cancer Med. 2013; 2 (2): 178-184.
5. Портной С.М. Возможности лечения отечно-инфильтративной формы рака молочной железы: Материалы VIII Российского онкологического конгресса. М., 2004. 31-35.
6. Lee K.W., Chung S.Y., Yang I. et al. Inflammatory breast cancer: imaging findings. Clin. Imaging. 2005; 29: 22-25.
7. Alunni J.P. Imaging inflammatory breast cancer. Diagn. Interv. Imaging. 2012; 93 (2): 95-103.
8. Маммология: Национальное руководство; Под ред. Харченко В.П., Рожкова Н.И. М.: ГЭОТАР-Медиа, 2009. 60 с.
9. Yang W.T., Le-Petross H.T., Macapinlac H. et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res. Treat. 2008; 109: 417-426.
10. GQnhan-Bilgen I., Ustun E.E., Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. 2002; 223: 829-838.
11. Tardivon A.A., Viala J., Corvellec R.A. et al. Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur. J. Radiol. 1997; 24: 124-130.
12. Kushwaha A.C., Whitman G.J., Stelling C.B. et al. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. Am. J. Roentgenol. 2000; 174: 535-538.
13. Клиническая маммология. Тематический сборник. 1-е изд; Под ред. Харченко В.П., Рожкова Н.И. М.: Стром, 2005. 74 с.
14. Le-Petross H., Uppendahl L., Stafford J. et al. Sonographic Features of Inflammatory Breast Cancer. Seminars Roentgenol. 2011; 46 (4): 275-279
15. Vlastos G., Fornage B.D., Mirza N.Q. et al. The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am. J. Surg. 2000; 179: 446-452.
16. Amant F., Loibl S., Neven P. et al. Breast cancer in pregnancy. Lancet. 2012; 379 (9815): 570-579.
17. Rosen E.L., Blackwell K.L., Baker J.A. et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am. J. Roentgenol. 2003; 181: 1275-1282.
18. Cheung Y.C., Chen S.C., Su M.Y. et al. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res. Treat. 2003; 78: 51-58.
19. Hylton N. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn. Reson. Imaging Clin. N. Am. 2006; 14: 383-389.
20. Thukral A., Thomasson D.M., Chow C.K. et al. Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab-initial experience. Radiology. 2007; 244: 727-735.
21. Chen J.H., Mehta R.S., Nalcioglu O. et al. Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response? Ann. Surg. Oncol. 2008; 15: 3609-3613.
22. Le-Petross C.H., Luc B., Yang W.T. Evolving Role of Imaging Modalities in Inflammatory Breast Cancer. Seminars Oncol. 2008; 35 (1): 51-63.
23. Carbognin G., Calciolari C., Girardi V. et al. Inflammatory breast cancer: MR imaging findings. Radiol. Med. 2010; 115: 70-82.
24. Thomassin-Naggara I., De Bazelaire C., Chopier J. et al. Diffusion-weighted MR imaging of the breast: advantages and pitfalls. Eur. J. Radiol. 2013; 82: 435-443.
25. Alikhassi A., Omranipour R., Alikhassy Z. et al. Congestive Heart Failure versus Inflammatory Carcinoma in Breast. Case Rep. Radiol. 2014: 815-896.
26. Wang L., Wang D., Fei X. et al. A Rim-Enhanced Mass with Central Cystic Changes on MR Imaging: How to Distinguish Breast Cancer from Inflammatory Breast Diseases? PLoS One. 2014; 9 (3): 90355.
27. Le-Petross H.T., Cristofanilli M., Carkaci S. et al. MRI features of inflammatory breast cancer. Am. J. Roentgenol. 2011; 197: 769-776.
28. Yamauchi H., Woodward W.A., Valero V. et al. Inflammatory breast cancer: what we know and what we need to learn. Oncologist. 2012; 17 (7): 891-899.
29. Groheux D., Giacchetti S., Delord M. et al. 18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging. J. Nucl. Med. 2013; 54 (1): 5-11.
30. Walker G.V., Niikura N., Yang W. et al. Pretreatment Staging Positron Emission Tomography/Computed Tomography in Patients With Inflammatory Breast Cancer Influences Radiation Treatment Field Designs. Int. J. Radiat. Oncol., Biology, Physics. 2012; 83 (5): 1381-1386.
31. Schelling M., Avril N., Nahrig J. et al. Positron emission tomography using Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J. Clin. Oncol. 2000; 18: 1689-1695.
32. Mankoff D.A., Dunnwald L.K., Gralow J.R. et al. Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J. Nucl. Med. 2003; 44: 1806-1814.
33. Berg W.A., Weinberg I.N., Narayanan D. et al. High-resolution fluorodeoxyglucose positron emission tomography with compression (“positron emission mammography”) is highly accurate in depicting primary breast cancer. Breast J. 2006; 12: 309-323.
34. Carkaci S., Macapinlac H.A., Cristofanilli M. et al. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J. Nucl. Med. 2010; 50: 231-238.
35. Shigematsu H., Kadoya T., Masumoto N. et al. Role of FDG-PET/CT in Prediction of Underestimation of Invasive Breast Cancer in Cases of Ductal Carcinoma In Situ Diagnosed at Needle Biopsy. Clin. Breast Cancer. 2014; 14 (5): 358-364.
36. Ibusuki M., Yamamoto Y., Kawasoe T. et al. Potential advantage of preoperative three-dimensional mapping of sentinel nodes in breast cancer by a hybrid single photon emission CT (SPECT)/CT system. Surg. Oncol. 2010; 19(2): 88-94.
37. Uren R.F., Howman-Giles R., Chung D.K.V. et al. SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla. Breast J. 2012; 21 (4): 480-486.
Рецензия
Для цитирования:
Колесник А.Ю., Шершнева М.А., Меских Е.В., Чхиквадзе В.Д., Нуднов Н.В. Новые подходы к диагностическому алгоритму отечно-инфильтративной формы рака молочной железы (обзор литературы). Медицинская визуализация. 2014;(5):124-129.
For citation:
Kolesnik A.Yu., Sherhneva M.A., Meskih E.V., Chkhikvadze V.D., Nudnov N.V. The Modern Approaches in Diagnostic Algorithm of Inflammatory Breast Cancer (The Literature Review). Medical Visualization. 2014;(5):124-129. (In Russ.)